» Articles » PMID: 19308750

Oxidative Stress but Not Endothelial Dysfunction Exists in Non-obese, Young Group of Patients with Polycystic Ovary Syndrome

Overview
Publisher Wiley
Date 2009 Mar 25
PMID 19308750
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine if oxidative stress and endothelial dysfunction exist at the same time in a young, non-obese group of patients with polycystic ovary syndrome (PCOS).

Design: Cross-sectional study.

Setting: Celal Bayar University, School of Medicine, Manisa, Turkey.

Sample: Thirty-one young, non-obese patients with PCOS and 23 age- and body mass index-matched controls.

Methods: Following clinical and biochemical diagnosis, malonyldialdehyde (MDA), superoxide dismutase (SOD), von Willebrand Factor (vWF), and nitric oxide (NO) levels of patients and controls were measured and compared.

Main Outcome Measures: To find out oxidative stress and endothelial dysfunction parameters.

Results: MDA (0.12+/-0.03 vs 0.10+/-0.03, p=0.01) and SOD (8.0+/-0.7 vs 7.28+/-0.8, p=0.001) levels were significantly higher in PCOS group while there was no difference in vWF (527.2+/-280.1 vs 568.1+/-276.8, p>0.05) and NO levels (169.9+/-47.4 vs 168.9+/-80, p>0.05). When the results of the PCOS patients were divided into two subgroups in terms of insulin resistance (IR- and IR + ), the IR- subgroup had significantly higher MDA levels compared to the control (0.125+/-0.03 vs 0.101+/-0.03, p=0.03). Though IR+ group also had higher MDA than the control group, it did not reach to a significant level (0.117+/-0.05 vs 0.101+/-0.03, p>0.05). Both IR- and IR+ groups had significantly higher SOD levels compared with control group (7.99+/-0.7 vs 7.28+/-0.8, p=0.009 and 8.22+/-0.8 vs 7.28+/-0.8, p=0.03, respectively). vWF and NO levels were not different among these three groups (p>0.05).

Conclusions: Oxidative stress is prominent while endothelial dysfunction does not exist in young, non-obese patients with PCOS.

Citing Articles

Mechanisms and Target Parameters in Relation to Polycystic Ovary Syndrome and Physical Exercise: Focus on the Master Triad of Hormonal Changes, Oxidative Stress, and Inflammation.

Lorincz C, Borzsei D, Hoffmann A, Varga C, Szabo R Biomedicines. 2024; 12(3).

PMID: 38540173 PMC: 10968456. DOI: 10.3390/biomedicines12030560.


Elevated serum malondialdehyde (MDA), insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid- stimulating hormone (TSH), and reduced antioxidant vitamins in polycystic ovarian syndrome patients.

Mahmud A, Anu U, Foysal K, Hasan M, Sazib S, Ragib A Narra J. 2024; 2(1):e56.

PMID: 38450391 PMC: 10914094. DOI: 10.52225/narra.v2i1.56.


Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D.

Nandakumar M, Sathyapalan T, Butler A, Atkin S Biomedicines. 2023; 11(7).

PMID: 37509682 PMC: 10377564. DOI: 10.3390/biomedicines11072044.


Heavy Metals and Essential Elements in Association with Oxidative Stress in Women with Polycystic Ovary Syndrome-A Systematic Review.

Srnovrsnik T, Virant-Klun I, Pinter B Antioxidants (Basel). 2023; 12(7).

PMID: 37507937 PMC: 10376316. DOI: 10.3390/antiox12071398.


Association of Serum Selenium and Selenoprotein P with Oxidative Stress Biomarkers in Patients with Polycystic Ovary Syndrome.

Amirkhizi F, Taghizadeh M, Khalese-Ranjbar B, Hamedi-Shahraki S, Asghari S Biol Trace Elem Res. 2023; 202(3):947-954.

PMID: 37391553 DOI: 10.1007/s12011-023-03747-4.